Targeting the Gut Microbiota for the Treatment of Non-Alcoholic Fatty Liver Disease

E-ISSN： 1873-5592|16|12|1324-1331

ISSN： 1389-4501

Source： Current Drug Targets, Vol.16, Iss.12, 2015-10, pp. : 1324-1331

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Current best treatment for non-alcoholic fatty liver disease

By Angulo Paul

Expert Opinion on Pharmacotherapy, Vol. 4, Iss. 5, 2003-05 ,pp. : 611-623

Informa Healthcare

Access to resources Recommend Favorite

Treatment of non-alcoholic fatty liver disease with focus on emerging drugs

By Marchesini Giulio Moscatiello Simona Agostini Federica Villanova Nicola Festi Davide

Expert Opinion on Emerging Drugs, Vol. 16, Iss. 1, 2011-03 ,pp. : 121-136

Informa Healthcare

Access to resources Recommend Favorite

Current Treatment Strategies for Non-Alcoholic Fatty Liver Disease (NAFLD)

Current Drug Discovery Technologies, Vol. 4, Iss. 2, 2007-08 ,pp. : 133-140

Bentham Science Publishers

Access to resources Recommend Favorite

Recent advances in the treatment of non-alcoholic fatty liver disease

By Mendes Flavia D Lindor Keith D

Expert Opinion on Investigational Drugs, Vol. 14, Iss. 1, 2005-01 ,pp. : 29-35

Informa Healthcare

Access to resources Recommend Favorite

Emerging drugs for non-alcoholic fatty liver disease

By Federico Alessandro Niosi Marco Vecchio Blanco Camillo Del Loguercio Carmela

Expert Opinion on Emerging Drugs, Vol. 13, Iss. 1, 2008-03 ,pp. : 145-158

Informa Healthcare

Access to resources Recommend Favorite